May 14, 2024, 3:01 PM
May 10, 2024, 8:08 PM
Novavax Stock Triples Following $1.3 Billion Sanofi Deal
- Novavax's stock nearly tripled over two days after signing a commercialization deal with Sanofi.
- The deal includes a licensing agreement and a minority stake from the pharmaceutical giant.
- Investors are optimistic about the future prospects of Novavax following the significant financial agreement.
Opinions
You've reached the end